Cargando…
Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study
BACKGROUND: Patients with lung cancer are more likely to have comorbidities [e.g., interstitial lung disease (ILD)], chronic obstructive pulmonary disease) and metastases that may affect dyspnea and the effectiveness and safety of opioids for dyspnea than other cancer types. Therefore, this study ex...
Autores principales: | Taniguchi, Yoshihiko, Matsuda, Yoshinobu, Mori, Masanori, Ito, Madoka, Ikari, Tomoo, Tokoro, Akihiro, Aiki, Sayo, Hoshino, Shunya, Kiuchi, Daisuke, Suzuki, Kozue, Igarashi, Yuko, Odagiri, Takuya, Oya, Kiyofumi, Kubo, Emi, Yamaguchi, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830271/ https://www.ncbi.nlm.nih.gov/pubmed/36636410 http://dx.doi.org/10.21037/tlcr-22-512 |
Ejemplares similares
-
Research policy in supportive care and palliative care for cancer dyspnea
por: Matsuda, Yoshinobu, et al.
Publicado: (2021) -
The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study
por: Mori, Masanori, et al.
Publicado: (2022) -
Physician-Perceived Predictive Factors for the Effectiveness of Drugs for Treating Cancer Dyspnea: Results of a Nationwide Survey of Japanese Palliative Care Physicians
por: Matsuda, Yoshinobu, et al.
Publicado: (2020) -
“3‐Day Surprise Question” to predict prognosis of advanced cancer patients with impending death: Multicenter prospective observational study
por: Ikari, Tomoo, et al.
Publicado: (2020) -
Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report
por: Tanaka-Yagi, Yukako, et al.
Publicado: (2022)